Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Molecular Targeting Technologies Inc.
DescriptionGlucarate-based nuclear imaging agent
Molecular Target
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase II
Standard IndicationCancer, Diagnostic
Indication DetailsDetect breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today